BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23547834)

  • 1. Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia.
    Sugita F; Maki K; Nakamura Y; Sasaki K; Mitani K
    Leuk Lymphoma; 2014 Jan; 55(1):78-86. PubMed ID: 23547834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
    Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F
    Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
    Thoene S; Rawat VP; Heilmeier B; Hoster E; Metzeler KH; Herold T; Hiddemann W; Gökbuget N; Hoelzer D; Bohlander SK; Feuring-Buske M; Buske C
    Leukemia; 2009 Apr; 23(4):649-55. PubMed ID: 19158837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia.
    Fang Q; Zhao X; Li Q; Li Y; Liu K; Tang K; Wang Y; Liu B; Wang M; Xing H; Rao Q; Tian Z; Wang J; Mi Y
    Leuk Lymphoma; 2017 Jan; 58(1):127-137. PubMed ID: 27157479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of MIR9 indicates poor prognosis in acute myeloid leukaemia.
    Maki K; Yamagata T; Sugita F; Nakamura Y; Sasaki K; Mitani K
    Br J Haematol; 2012 Jul; 158(2):283-285. PubMed ID: 22489576
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.
    Wang Y; Chen G; Cao R; Li J; He L; Guo X; Liang J; Shi P; Zhou Y; Xu B
    Pharmacogenomics; 2017 Jan; 18(1):77-84. PubMed ID: 27967319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study.
    Todorovic M; Radisavljevic Z; Balint B; Andjelic B; Todorovic V; Jovanovic MP; Mihaljevic B
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):488-93. PubMed ID: 22417860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the rapidity of bone marrow blast cell proliferation in adult acute lymphoblastic leukemia.
    Pich A; Chiusa L; Ceretto C; Fornari A; Audisio E; Marmont F; Navone R
    Leukemia; 2004 Jan; 18(1):172-4. PubMed ID: 14586475
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
    Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia.
    Juárez-Velázquez R; Reyes-León A; Salas-Labadía C; Rivera-Luna R; Velasco-Hidalgo L; López-Hernández G; López-Santiago N; Paredes-Aguilera R; Domínguez-López A; Bernáldez R; Pérez-Vera P
    Leuk Lymphoma; 2014 Oct; 55(10):2305-11. PubMed ID: 24397596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stanniocalcin1 gene expression in patients with acute leukemia: impact on response to therapy and disease outcome.
    Abaza HM; Elmougy MI; El Maraghy HM; Mahmoud HM
    Int J Lab Hematol; 2016 Feb; 38(1):81-9. PubMed ID: 26547904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
    Forghieri F; Luppi M; Potenza L
    Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
    [No Abstract]   [Full Text] [Related]  

  • 19. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells.
    Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR
    Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.